Business

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

Financial Post · September 16, 2026 at 8:27 a.m.

Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workers VANCOUVER, British Columbia, Sept.

16, 2026 (GLOBE NEWSWIRE) — Optimi He

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

More from Financial Post

Globex Mining Enterprises Inc. Announces Normal Course Issuer Bid

Netflix is paying US$200 million for 2027 Women’s World Cup

ZenaTech Unveils Stacklens™, AI-Powered Smart Safety Glasses Built for Field Technicians and Industrial Workers

OpenAI expects US$70 billion in annualized revenue by end of 2026

More in Business

Globex Mining Enterprises Inc. Announces Normal Course Issuer Bid

Netflix is paying US$200 million for 2027 Women’s World Cup

ZenaTech Unveils Stacklens™, AI-Powered Smart Safety Glasses Built for Field Technicians and Industrial Workers

OpenAI expects US$70 billion in annualized revenue by end of 2026

ADAMnetworks Launches ClickNix, a Free Browser Extension to Stop ClickFix Attacks Before They Ever Reach the User

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment